HAPIMMUNE Trademark

Trademark Overview

On Monday, January 11, 2021, a trademark application was filed for HAPIMMUNE with the United States Patent and Trademark Office. The USPTO has given the HAPIMMUNE trademark a serial number of 90458002. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 16, 2025. This trademark is owned by AETHON THERAPEUTICS, INC.. The HAPIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
hapimmune

General Information

Serial Number90458002
Word MarkHAPIMMUNE
Filing DateMonday, January 11, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAETHON THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10169
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNew York, NY 10016
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Thursday, January 14, 2021NEW APPLICATION ENTERED
Thursday, January 14, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 14, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, April 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Sunday, July 25, 2021SUSPENSION LETTER WRITTEN
Sunday, July 25, 2021LETTER OF SUSPENSION E-MAILED
Sunday, July 25, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 27, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 30, 2021ASSIGNED TO LIE
Thursday, December 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 7, 2022SOU EXTENSION 1 FILED
Monday, November 7, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 10, 2023SOU EXTENSION 2 FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, June 21, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, July 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, July 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, July 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 25, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 25, 2023PETITION TO REVIVE-GRANTED
Tuesday, July 25, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 26, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, August 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 22, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 12, 2023SOU EXTENSION 3 FILED
Thursday, October 12, 2023SOU EXTENSION 3 GRANTED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024SOU EXTENSION 4 FILED
Friday, April 19, 2024SOU EXTENSION 4 GRANTED
Tuesday, October 29, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, October 29, 2024SOU EXTENSION 5 FILED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Saturday, April 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, November 1, 2024DIVISIONAL PROCESSING COMPLETE
Friday, November 1, 2024SOU EXTENSION 5 GRANTED
Monday, June 16, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, June 16, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, November 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2024CORRECTED NOA E-MAILED

Related Keywords

hapimmune gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related